A polydopamine nanomedicine used in photothermal therapy for liver cancer knocks down the anti-cancer target NEDD8-E3 ligase ROC1 (RBX1)

Overview of attention for article published in Journal of Nanobiotechnology, October 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 2,815 followers.

New article: A polydopamine nanomedicine used in photothermal therapy for liver cancer knocks down the anti-cancer target NEDD8-E3 ligase ROC1 (RBX1) https://t.co/miqvdT9mqx #livercancer #oncology https://t.co/gDt3nueEgM

RT @JNanobiotech: New online: Photothermal polydopamine siRNA nanovectors knock down the anti-cancer target NEDD8-E3 ligase ROC1 (RBX1) in…

RT @JNanobiotech: New online: Photothermal polydopamine siRNA nanovectors knock down the anti-cancer target NEDD8-E3 ligase ROC1 (RBX1) in…

New online: Photothermal polydopamine siRNA nanovectors knock down the anti-cancer target NEDD8-E3 ligase ROC1 (RBX1) in liver cancer. https://t.co/SXMpFmELeG https://t.co/OEzbStFzfu

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.